Percutaneous Coronary Intervention (PCI)
Procedureballoon angioplasty
NCT Number: NCT01180517
The intention of this trial is to assess the safety and efficacy of Drug Eluting Balloon (DEB) application (SeQuent Please) to the side branch in percutaneous coronary intervention (PCI) of Medina 0,0,1 coronary bifurcation lesions. Patients will be randomized to treatment with Plain Old Balloon Angioplasty (POBA)or treatment with DEB.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Herzzentrum Dresden, Dresden, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(main):
Exclusion criteria
(main):
balloon angioplasty
balloon angioplasty
Time frame: 9 months
Ralf Degenhardt, PhD
Other
The Paclitaxel-Eluting PTCA-Balloon Catheter for the Treatment of Coronary Bifurcations
Acronym: PEPCAD-BIF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00821028
Angioplasty, Arterial Occlusive Diseases
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT02753998
Angioplasty, Stenosis of Arteriovenous Fistula
Boulogne-Billancourt, Hauts-de-Seine, France
View Trial DetailsNCT03115723
Angioplasty, Coronary Angiography
Agen, France
View Trial DetailsNCT03673254
Angioplasty
Vienna, Austria
View Trial Details